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ABSTRACT
Objectives To describe the characteristics, clinical 
management and outcomes of patients with COVID-19 at 
district hospitals.
Design A descriptive observational cross- sectional study.
Setting District hospitals (4 in metro and 4 in rural 
health services) in the Western Cape, South Africa. District 
hospitals were small (<150 beds) and led by family 
physicians.
Participants All patients who presented to the hospitals’ 
emergency centre and who tested positive for COVID-19 
between March and June 2020.
Primary and secondary outcome measures Source 
of referral, presenting symptoms, demographics, 
comorbidities, clinical assessment and management, 
laboratory turnaround time, clinical outcomes, factors 
related to mortality, length of stay and location.
Results 1376 patients (73.9% metro, 26.1% rural). Mean 
age 46.3 years (SD 16.3), 58.5% females. The majority 
were self- referred (71%) and had comorbidities (67%): 
hypertension (41%), type 2 diabetes (25%), HIV (14%) 
and overweight/obesity (19%). Assessment of COVID-19 
was mild (49%), moderate (18%) and severe (24%). Test 
turnaround time (median 3.0 days (IQR 2.0–5.0 days)) was 
longer than length of stay (median 2.0 day (IQR 2.0–3.0)). 
The most common treatment was oxygen (41%) and only 
0.8% were intubated and ventilated. Overall mortality was 
11%. Most were discharged home (60%) and only 9% 
transferred to higher levels of care. Increasing age (OR 
1.06 (95% CI 1.04 to 1.07)), male (OR 2.02 (95% CI 1.37 
to 2.98)), overweight/obesity (OR 1.58 (95% CI 1.02 to 
2.46)), type 2 diabetes (OR 1.84 (95% CI 1.24 to 2.73)), HIV 
(OR 3.41 (95% CI 2.06 to 5.65)), chronic kidney disease 
(OR 5.16 (95% CI 2.82 to 9.43)) were significantly linked 
with mortality (p<0.05). Pulmonary diseases (tuberculosis 
(TB), asthma, chronic obstructive pulmonary disease, 
post- TB structural lung disease) were not associated with 
increased mortality.
Conclusion District hospitals supported primary care 
and shielded tertiary hospitals. Patients had high levels of 
comorbidities and similar clinical pictures to that reported 
elsewhere. Most patients were treated as people under 
investigation. Mortality was comparable to similar settings 
and risk factors identified.
INTRODUCTION
COVID-19 is a global pandemic that has 
affected all regions of the world, although 
Africa has so far been less affected than 
predicted.1 Given the number of low- and 
middle- income countries, and relatively weak 
health systems, the pandemic is expected to 
significantly impact African communities.2 
Within the African continent, South Africa 
has had the most reported cases and the 
Western Cape has been one of the leading 
hotspots.1 3
Clinical findings among confirmed 
COVID-19 cases in China showed the most 
common complaints were fever (83%), cough 
(82%), difficulty breathing (31%), fatigue 
and myalgia (11%).4 Non- respiratory injury 
was identified by elevated levels of aspartate 
aminotransferase (20%), creatinine (6%) 
and creatine kinase (15%).5
Strengths and limitations of this study
 ► The whole study population was included over a 
4- month period at the height of the epidemic from 
eight district hospitals with few missing records.
 ► A comprehensive dataset on presentation, assess-
ment, management and outcomes was captured.
 ► The size of the study population enabled identifica-
tion of risk factors associated with mortality.
 ► Data were dependent on the accuracy of medical 
records and clinical skills.
 ► District hospitals without family physicians may have 
different quality of care, which limits generalisability.
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Findings from another Chinese study showed that 
older patients and those with comorbidity had poorer 
clinical outcomes.5 Multimorbidity was also correlated 
with poorer clinical outcomes.6 Comorbidity with cardio-
pulmonary diseases was a particular concern, such as 
diabetes, hypertension, asthma and chronic obstructive 
pulmonary disease (COPD). In South Africa, there was 
also concern with regard to the large numbers of people 
with HIV, particularly those who were immunocompro-
mised, due to no or inadequate antiretroviral treatment. 
South Africa has 20% of all people living with HIV in the 
world and this is accompanied by a high incidence of 
tuberculosis (TB).7 8 Patients with active TB or post- TB 
structural lung damage were also a concern in our 
context.
Most clinical research has focused on tertiary hospi-
tals with high- care or intensive care units (ICU). Little 
is known, therefore, about the types of patients seen at 
district hospitals and their clinical course with the exper-
tise and equipment available at this level of the health 
system and in this African context. In South Africa, district 
hospitals usually have <150 beds and are run by general-
ists with male, female, maternity and paediatrics wards as 
well as emergency centres (EC). They are the first referral 
point, particularly in remote and rural areas, for patients 
from primary care.
In Africa, primary or district hospitals do not provide 
intensive or critical care and have limited capacity for 
prolonged ventilation. At the same time, tertiary referral 
hospitals may not be able to receive patients if their ICU 
facilities are full or they are very distant. Elsewhere in 
Africa it has been suggested that district hospitals should 
focus more on the provision of oxygen therapy as a more 
valuable intervention than ventilation, as ventilation 
requires adequate equipment and expertise, with a risk of 
harm to the patient and transmission of the virus during 
intubation.9 Guidelines have also been put in place to 
determine which patients should be prioritised for ICU 
and which critically ill patients should be managed with 
oxygen and if necessary palliative care.10 In June 2020, 
Cape Town also opened field hospitals, which had the 
ability to manage patients with COVID-19 at a level of 
care similar to a district hospital.11
This study will describe the type of patients referred to 
district hospitals run by family physicians in the Western 
Cape and evaluate their presentation, clinical manage-
ment and outcomes. This data will help to provide a more 
complete picture of how COVID-19 is affecting our popu-
lation as the patient population seen at district hospitals 
is different to that seen at tertiary hospitals and African 
populations may differ from those in Europe, Asia or 
America.
The aim of this study, therefore, was to describe the 
characteristics, clinical management and outcomes of 
patients with COVID-19 presenting to district hospitals 
in the Western Cape from March 2020 to June 2020. 
The specific objectives were to describe the original 
source of referral, the presenting symptoms, the patients’ 
demographics, the presence of comorbidities, the clin-
ical assessment and management, the turnaround time 
(TOT) for laboratory results, the clinical outcomes and 
factors related to mortality, the length of stay and to 
compare district hospitals in rural health services (RHS) 
and metro health services (MHS).
METHODS
Study design
This was a descriptive observational cross- sectional study 
by means of a retrospective audit of medical records.
Setting
The Western Cape had 33 district hospitals: 28 small 
(<150 beds), 3 medium (150–299 beds) and 2 large 
(300–600 beds). Small district hospitals in this study 
operated as generalist environments with family physi-
cians as the most senior clinicians (one district hospital 
had an internal medicine physician running their inpa-
tient COVID-19 ward). A family physician is a specialist 
in family medicine. In South Africa, family physicians are 
trained for the district hospital setting as well as primary 
care.
In terms of the continuum of care for COVID-19, 
these district hospitals received patients from the public 
sector primary care facilities in their catchment area. 
The private sector could also refer patients, without 
insurance, to the district hospitals. Patients in primary 
care, with more than mild symptoms, were referred for 
further management, although those requiring critical or 
intensive care could be referred directly to regional or 
tertiary hospitals. Therefore, the profile of patients seen 
and treated at district hospitals will be different to those 
referred to regional and tertiary hospitals as the capacity 
for critical care and intensive care was much less or non- 
existent. These small district hospitals typically had ECs 
and re- organised their wards into ‘hot’ and ‘cold’ streams 
for COVID-19. Patients could be intubated and ventilated 
in the EC, prior to transfer, and there was not usually 
access to high flow oxygen, which was only installed in 
June in some hospitals. District hospitals could discharge 
patients to home, transfer them to a field hospital or to 
higher- level care.
Study population and selection of participants
The study engaged the Stellenbosch University Family 
Physician Research Network and the family physicians 
within that network who worked at small district hospi-
tals in the province. Eight district hospitals, four from 
the MHS in Cape Town and three in the RHS, opted to 
take part. The study excluded medium- large metropol-
itan district hospitals that were organised along specialist 
departmental lines and which delivered a different 
package of care. George Regional Hospital was also 
included in the RHS, as its Department of Family Medi-
cine offered district hospital services to the surrounding 
area and ran the EC.
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From these eight facilities, all patients who presented 
to the EC and who tested positive for COVID-19 were 
included between March and June 2020. There was no 
sampling or other exclusion criteria.
Data collection
Patients were identified from the laboratory results and 
their folders drawn from the records department. Data 
were extracted from the medical records using a stan-
dardised data collection tool by the family physicians at 
each hospital. Data were collected electronically using 
REDCap software on internet- connected devices available 
to the researchers. Overweight and obesity were defined 
as a body mass index >25 kg/m2. The South African Triage 
Scale was used by clinicians where red is for an immediate 
emergency, orange is very urgent, yellow is urgent and 
green is non- urgent.12 COVID-19 was classified according 
to clinical guidelines issued by the Western Cape Govern-
ment: Health.13
The data collection tool was designed to collect data on 
the objectives listed above and the tool was validated by 
all the family physicians involved in the study prior to data 
collection. The tool was piloted by one district hospital 
prior to use.
Data analysis
Data were exported from REDCap to the Statistical 
Package for Social Sciences V.26. There was no missing 
data. Means with SD were used to describe continuous 
variables that were normally distributed and medians with 
IQRs to describe continuous data that were not normally 
distributed. Categorical data were analysed using frequen-
cies and percentages.
Categorical variables were compared by Pearson’s χ2 
test. An independent T- test was used to compare contin-
uous variables with binary variables if data were normally 
distributed and a Mann- Whitney U test if data were not 
normally distributed. Analysis of variance was used to 
compare nominal variables with normally distributed 
numeric variables.
Univariate binary logistic regression was used to deter-
mine ORs for factors that might be associated with 
mortality (age, sex, comorbidities and location). Factors 
with a p value <0.1 were then entered into a multiple vari-
able forward stepwise binary logistic regression to deter-
mine which factors remained significantly associated with 
mortality.
Patient and public involvement
Patients and/or the public were not involved in the 




Overall, 1376 patients were included in the study for 
this period and 1017 (73.9%) were from the MHS and 
359 (26.1%) from RHS. The mean age of patients was 
46.3 years (SD 16.3 years) and patients were significantly 
older in the MHS compared with RHS (MHS 48.1 years 
(SD 16.1), RHS 41.4 years (SD 15.7), mean difference 
6.73 years (4.80–8.66), p<0.001). Overall, there were 571 
(41.5%) males and 805 (58.5%) females. There were 
significantly more females in the MHS sample than RHS 
(60.9% vs 51.8% female, p=0.003).
Presentation and assessment
Table 1 shows the characteristics of patients on arrival at 
the EC. Only 10% of patients were referred from public 
sector primary care facilities and the majority (70.6%) 
were self- referred. Patients were significantly more likely 
to be referred from a primary care facility in the RHS as 
shown in table 1.
The most common symptoms were cough, shortness 
of breath, fever, body pains/myalgia and sore throat. 
The most common abnormal clinical signs were a raised 
respiratory rate, tachycardia, hyperglycaemia, decreased 
oxygen saturation and raised systolic blood pressure. 
The impression was that MHS patients were sicker (more 
dyspnoea, lower oxygen saturation, more confused) than 
those in the RHS at presentation and RHS patients had 
more symptoms from an earlier phase of the disease (sore 
throat, myalgia, nasal symptoms, cough).
Table 2 presents the comorbidities of patients. A third of 
patients had no known comorbidities. The most common 
comorbidities were hypertension, type 2 diabetes, over-
weight/obesity and HIV. Patients in the MHS had signifi-
cantly more comorbidities than those in the RHS. On 
arrival the levels of prior control for many comorbidities 
was unknown, particularly in the rural areas. People with 
type 2 diabetes had the highest proportion that were 
uncontrolled.
Table 3 presents the initial assessment and final dispo-
sition from the EC. There was some mismatch between 
the initial triage and final assessment, with 53.1% of 
patients triaged as yellow and 17.1% of patients triaged as 
orange, being clinically assessed as mild COVID-19, and 
half (49.1%) of all patients were assessed as mild. Patients 
from the RHS were significantly more likely to be assessed 
as mild and less likely to be admitted. Overall, 42.2% were 
discharged home from the EC, 47.4% admitted and only 
6.2% transferred immediately to a higher level of care.
Management in hospital
Most patients were admitted as people under investigation 
and managed without a definitive diagnosis, as the TOT 
for the test result (median 3.0 days (IQR 2.0–5.0 days)) 
was longer than the length of stay (median 2.0 day (IQR 
2.0–3.0)). There was no difference in the TOT between 
MHS and RHS (MHS median 3.0 days (IQR 3.0–4.0) and 
RHS 2.0 days (IQR 2.0–3.0), p=0.113).
Half of all patients did not receive a chest radiograph 
in the EC or on admission (695 (50.5%)) and this was 
significantly more likely in rural areas (MHS 41.9% 
vs RHS 74.7%, p<0.001). The typical appearance was 
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bilateral changes in the lower or mid- zone, a ground glass 
appearance or consolidation. There were no major differ-
ences in the radiograph findings between MHS and RHS.
Table 4 presents the treatments for COVID-19. Only 
40.6% received any form of oxygen therapy and very 
few were intubated (0.8%). Those admitted were usually 
treated with oxygen, low molecular weight heparin (enox-
aparin sodium) and antibiotics (ceftriaxone, azithromycin 
or co- amoxiclav) and far fewer patients were treated with 
proning or steroids. Proning was only used in 24% of 
those with severe or critical COVID-19.
Table 5 presents the final clinical outcomes. The overall 
mortality rate was 11.0% and 19.6% for those admitted. 
Mortality rose to 57.3% for those that were critically ill, 
21.8% for severe cases, 7.5% for moderate cases and 1.8% 
for mild. Half of those admitted were discharged home 









n (%) P value
Source of referral
Primary care facility 137 (10.0) 69 (6.8) 68 (18.9) <0.001
Private general practice 147 (10.7) 105 (10.3) 42 (11.7)
Self- referral 972 (70.6) 736 (72.4) 235 (65.5)
Higher hospital 5 (0.4) 5 (0.5) 0 (0.0)
Other 40 (2.9) 26 (2.6) 14 (3.9)
Not known 75 (5.5) 75 (7.4) 0 (0.0)
Symptoms recorded on arrival
Sore throat 332 (24.1) 186 (18.3) 146 (40.7) <0.001
Nasal symptoms 93 (6.8) 61 (6.0) 32 (8.9) 0.059
Body pains/myalgia 360 (26.2) 248 (24.4) 112 (31.2) 0.012
Fever 441 (32.0) 302 (29.7) 139 (38.7) 0.002
Cough 877 (63.7) 612 (60.2) 265 (73.8) <0.001
Shortness of breath 717 (52.1) 545 (53.6) 172 (47.9) 0.062
Fatigue 181 (13.2) 155 (15.3) 26 (7.2) <0.001
Loss smell 64 (4.7) 43 (4.2) 21 (5.8) 0.211
Loss taste 49 (3.6) 29 (2.9) 20 (5.6) 0.017
Diarrhoea 82 (6.0) 70 (6.9) 12 (3.3) 0.015
Headache 222 (16.1) 157 (15.5) 65 (18.1) 0.240
Other 298 (21.7) 250 (24.6) 47 (13.1) <0.001
Observations recorded on arrival
Temperature >37.5°C 162 (12.4) 96 (10.0) 66 (19.0) <0.001
Respiratory rate >18/min 650 (50.5) 505 (52.7) 145 (43.9) 0.007
Pulse rate >100/min 646 (47.9) 491 (49.3) 154 (43.8) 0.013
Systolic BP <90 mm Hg 31 (2.6) 28 (3.2) 3 (1.0) 0.08
Systolic BP >140 mm Hg 360 (30.0) 259 (29.3) 101 (32.3)
Diastolic BP <60 mm Hg 101 (8.4) 87 (9.8) 14 (4.5) 0.008
Diastolic BP >90 mm Hg 217 (18.1) 152 (17.2) 65 (20.7)
Oxygen saturation <95% 557 (41.9) 439 (44.8) 118 (33.8) <0.001
Random blood glucose <4.0 mmol/L 22 (2.5) 15 (2.1) 7 (3.9) 0.228
Random blood glucose >7.8 mmol/L 397 (44.3) 324 (45.4) 73 (40.3)
Alert 1264 (91.9) 921 (90.6) 342 (95.3) 0.034
Confused but responds to verbal commands 82 (6.0) 69 (6.8) 13 (3.6)
Unconscious but responds to pain 10 (0.7) 7 (0.7) 3 (0.8)
Unconscious with no response to pain 6 (0.4) 5 (0.5) 1 (0.3)
BP, blood pressure; EC, emergency centre.
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n (%) P value
Comorbidity
Overweight/Obesity 269 (19.5) 208 (20.5) 61 (17.0) 0.153
Type 1 diabetes 17 (1.2) 15 (1.5) 2 (0.6) 0.175
Type 2 diabetes 347 (25.2) 273 (26.9) 74 (20.6) 0.019
Hypercholesterolaemia 83 (6.0) 77 (7.6) 6 (1.7) <0.001
Hypertension 564 (41.0) 454 (44.7) 109 (30.4) <0.001
Cardiac failure 58 (4.2) 51 (5.0) 7 (1.9) 0.013
Ischaemic heart disease 25 (1.8) 24 (2.4) 1 (0.3) 0.011
Asthma 67 (4.9) 52 (5.1) 15 (4.2) 0.477
COPD 50 (3.6) 38 (3.7) 12 (3.3) 0.729
Post- TB lung damage 12 (0.9) 8 (0.8) 4 (1.1) 0.567
HIV 195 (14.2) 156 (15.4) 39 (10.9) 0.036
Active TB on treatment 23 (1.7) 20 (2.0) 3 (0.8) 0.150
Previous TB 49 (3.6) 40 (3.9) 9 (2.5) 0.209
Cancer on treatment 10 (0.7) 9 (0.9) 1 (0.3) 0.244
Previous cancer 2 (0.1) 2 (0.2) 0 (0.0) 0.400
Chronic kidney disease 60 (4.4) 55 (5.4) 5 (1.4) 0.001
None 450 (32.7) 276 (27.2) 174 (48.5) <0.001
Tobacco smoker 95/621 (15.3) 80/490 (16.3) 15/131 (11.5) 0.168
Previous control of comorbidity
Diabetes n=348
Normal HbA1c <7% 32 (9.2) 30 (10.8) 2 (2.9) 0.002
Controlled HbA1c 7%–8% 41 (11.8) 34 (12.2) 7 (10.1)
Uncontrolled HbA1c >8 and <10% 68 (19.5) 56 (20.1) 12 (17.4)
Very uncontrolled ≥10% 131 (37.6) 110 (39.4) 21 (30.4)
Unknown 76 (21.8) 49 (17.6) 27 (39.1)
Hypertension n=446
Well controlled 165 (37.0) 150 (41.6) 14 (16.7) <0.001
Uncontrolled 88 (19.7) 75 (20.8) 13 (15.5)
Not known 193 (43.3) 136 (37.7) 57 (67.9)
Asthma n=72
Well controlled 23 (31.9) 21 (51.2) 2 (6.5) <0.001
Partly controlled 10 (13.9) 6 (14.6) 4 (12.9)
Uncontrolled 5 (6.9) 5 (12.2) 0 (0.0)
Unknown 34 (47.2) 9 (22.0) 25 (80.6)
COPD n=56
Mild 7 (12.5) 5 (15.6) 2 (8.3) <0.001
Moderate 11 (19.6) 9 (28.1) 2 (8.3)
Severe 13 (23.2) 12 (37.5) 1 (4.2)
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(49.7%) and only 8.7% were transferred to a higher level 
of care and this was significantly more likely in the MHS 
(p<0.001). The MHS also made use of the field hospitals.
Risk factors for mortality
In the multiple variable analysis, increasing age, male 
sex, overweight/obesity, type 2 diabetes, chronic kidney 
disease, cardiac failure, HIV and treatment for cancer were 
all independently associated with a higher risk of death 
(table 6). Chronic respiratory conditions, such as asthma, 
COPD, post- TB lung damage and tobacco smoking were 
not associated with increased risk of mortality. Hyperten-
sion and hypercholesterolaemia were also not retained as 
risk factors in the multiple variable analysis. There was no 
difference in risk of mortality between the MHS and RHS. 
In addition, there was a significant relationship between 
poorer categories of diabetic control and mortality (OR 
2.28 ((95% CI 1.25 to 4.16), p=0.007), but not with poor 
control of HIV (unsuppressed viral load) (OR 1.96 (95% 
CI 0.62 to 6.23), p=0.253). There was also no significant 
relationship with being on antiretroviral treatment (OR 
0.879 (95% CI 0.524 to 1.48), p=0.627).
DISCUSSION
Contribution of district hospitals to the health system 
response
The majority of people with COVID-19 were self- referred 
and bypassed the gatekeeping role expected of public 
sector primary care facilities. Primary care facilities are 









n (%) P value
Well controlled 96 (53.3) 79 (57.7) 17 (39.5) 0.004
Uncontrolled 22 (12.2) 15 (10.9) 7 (16.3)
Unknown 43 (23.9) 25 (18.2) 18 (41.9)
No ART 16 (8.9) 16 (11.7) 0 (0.0)
New on ART 3 (1.7) 2 (1.5) 1 (2.3)
ART, antiretroviral treatment; COPD, chronic obstructive pulmonary disease; HbA1c, haemoglobin A1c; TB, tuberculosis.
Table 2 Continued









n (%) P value
Initial assessment in emergency centre
Triage green 455 (33.1) 267 (26.4) 188 (53.1) <0.001
Triage yellow 292 (21.3) 200 (19.7) 91 (25.7)
Triage orange 516 (37.7) 453 (44.7) 63 (17.8)
Triage red 105 (7.7) 93 (9.2) 12 (3.4)
Mild COVID 676 (49.1) 443 (43.6) 232 (64.6) <0.001
Moderate COVID 252 (18.3) 191 (18.8) 61 (17.0)
Severe COVID 335 (24.3) 303 (29.8) 32 (8.9)
Critical COVID 82 (6.0) 72 (7.1) 10 (2.8)
Unknown COVID 31 (2.3) 7 (0.7) 24 (6.7)
Disposition from emergency centre
Discharged home 581 (42.2) 378 (37.2) 203 (56.5) <0.001
Transferred to higher level 85 (6.2) 66 (6.5) 19 (5.3)
Transferred to assisted isolation 12 (0.9) 2 (0.2) 10 (2.8)
Transferred to field hospital 20 (1.5) 19 (1.9) 1 (0.3)
Admitted to district hospital 652 (47.4) 531 (52.2) 121 (33.7)
Died 13 (0.9) 10 (1.0) 3 (0.8)
Other 13 (0.9) 11 (1.1) 2 (0.6)
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district hospital EC the next available point of access. 
Primary care facilities also de- escalated during the 
epidemic and people were turned away or advised to stay 
away as much as possible,14 while there was no restrictions 
on access to district hospitals. In some areas, primary care 
facilities temporarily closed when staff were infected. 
Although primary care facilities could test, the district 
hospitals had larger and more visible testing centres. 
This, in addition to fear of more severe disease and more 
trust in hospital- based services, may have led people to 
present directly to the hospital. In rural areas, where the 
hospital was more geographically distant, more people 
entered the system via primary care facilities. District 
hospitals, therefore, played an important role in primary 
care during the epidemic and this is reflected in the find-
ings that 49% of patients seen had mild COVID-19% and 
42% were immediately discharged home from the EC. 
This also reflects the need to improve access to primary 
care in South Africa.15
District hospitals reduced pressure on tertiary hospitals 
with ICU and critical care beds particularly for those with 
moderate and severe COVID-19. Of those with moderate 
COVID-19, only 9% were transferred to tertiary hospitals 
and mortality was 7.5%. For those with severe disease, 
17% were transferred and mortality was 22%, which 
compares favourably with reports from high- income 
settings.16 District hospitals were unable to manage criti-
cally ill patients, as they did not have ICU or critical care 
facilities.
The introduction of field hospitals, such as at the Cape 
Town International Convention Centre,17 also took pres-
sure off acute hospitals and 13.5% of patients were trans-
ferred for ongoing care thus creating additional capacity 
at the district hospital. The first field hospital only 












n (%) P value
Any form of oxygen 558 (40.6) 461 (70.7) 452 (44.5) 106 (29.5) <0.001
Oxygen by nasal prongs 1–4 L/min 265 (19.3) 212 (32.5) 226 (22.2) 39 (10.9) <0.001
Oxygen by facemask 6–10 L/min 240 (17.4) 212 (32.5) 207 (20.4) 33 (9.2) <0.001
Oxygen with non- rebreather reservoir bag 10–15 L/min 177 (12.9) 130 (19.9) 136 (13.4) 41 (11.4) 0.339
Oxygen high flow >15 L/min 12 (0.9) 8 (1.2) 6 (0.6) 6 (1.7) 0.058
Intubation and ventilation 11 (0.8) 3 (0.5) 5 (0.5) 6 (1.7) 0.031
Proning 142 (10.3) 105 (16.1) 135 (13.3) 7 (1.9) <0.001
Enoxaparin sodium any 583 (42.4) 503 (77.1) 504 (49.6) 79 (22.0) <0.001
Enoxaparin sodium 40 mg/day 308 (22.4) 272 (41.7) 250 (24.6) 58 (16.2) 0.001
Enoxaparin sodium 1 mg/kg daily 218 (15.8) 191 (29.3) 203 (20.0) 15 (4.2) <0.001
Enoxaparin sodium 1 mg/kg two times per day 74 (5.4) 57 (8.7) 67 (6.6) 7 (1.9) 0.001
Ceftriaxone 556 (40.4) 460 (70.6) 501 (49.3) 55 (15.3) <0.001
Azithromycin 541 (39.3) 427 (65.5) 440 (43.3) 101 (28.1) <0.001
Co- amoxiclav 166 (12.1) 106 (16.3) 80 (7.9) 86 (24.0) <0.001
Any steroid 253 (18.4) 183 (28.1) 196 (19.3) 57 (15.9) 0.151
Dexamethasone 111 (8.1) 78 (12.0) 83 (8.2) 28 (7.8) 0.825
Hydrocortisone 15 (1.1) 12 (1.8) 13 (1.3) 2 (0.6) 0.257
Prednisone 131 (9.5) 97 (14.9) 102 (10.0) 29 (8.1) 0.277


























Died 128 (19.6) 151 (11.0) 118 (11.6) 33 (9.2) 12 (1.8) 19 (7.5) 73 (21.8) 47 (57.3)
Discharged home 324 (49.7) 831 (60.4) 577 (56.8) 253 (70.5) 525 (77.7) 147 (58.3) 130 (38.8) 7 (8.5)
Transferred tertiary hospital 57 (8.7) 118 (8.6) 115 (11.3) 3 (0.8) 20 (3.0) 23 (9.1) 55 (16.4) 20 (24.4)
Transferred assisted isolation 30 (4.6) 47 (3.4) 20 (2.0) 27 (7.5) 26 (3.8) 11 (4.4) 3 (0.9) 0 (0.0)
Transferred field hospital 88 (13.5) 105 (7.6) 104 (10.2) 1 (0.3) 1.3 (1.9) 28 (11.1) 55 (16.4) 7 (8.5)
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opened in June 2020, the last month of this study period. 
At the field hospital, care might include management of 
comorbidities, palliative care or further recovery prior to 
discharge home.17
The differences between RHS and MHS appeared 
to represent differences in the type of patients and 
geographic access rather than health services. RHS 
appeared to have younger patients, more often referred by 
local primary care facilities, with fewer comorbidities and 
less severe disease, which translated into lower mortality 
and better outcomes. In the Western Cape, the rural 
district hospitals had good infrastructure, equipment and 
competent clinical teams led by family physicians.
No other studies were found reporting on district 
hospitals from low- income and middle- income countries. 
The few studies from the UK reporting on district hospi-
tals are not comparable as these hospitals offer specialist 
services and serve a different type of population.18 District 
or primary hospitals in our setting are small, often rural or 
remote, and led by generalists or family physicians. These 
types of hospitals are rare in high- income countries, but 
an important part of African health systems. Although 
district hospitals in the Western Cape are generally well 
resourced and led by family physicians, in other parts of 
Africa these hospitals may have significant skills, equip-
ment and infrastructure gaps.19 African populations are 
also younger and have a different profile of comorbidi-
ties with communicable diseases more prominent (such 
as HIV, TB and malaria). Poverty is also a major issue that 
impacts on access to healthcare as well as food security 
and malnutrition.19 It is therefore important to evaluate 
how people with COVID-19 are managed and what their 
outcomes are at this level of African health systems.
Management of COVID-19 at district hospitals
Patients presented with the typical symptoms of COVID-19 
that have also been reported elsewhere in Africa.20 Fever, 
however, was only found in 12% of patients and many 
patients had hyperglycaemia and high blood pressure, 
reflecting underlying comorbidities. Family physicians 
reported that the procedures to use infrared thermom-
eters to triage patients may not have resulted in accurate 
measurements and therefore fever may be underob-
served.21 Not all patients had a body mass index measured 
and overweight/obesity was probably under- reported.
As the median TOT for COVID-19 tests was longer 
than the median length of admission, most patients 
were managed as people under investigation, who were 
presumed to have COVID-19. The laboratory capacity and 
TOT for COVID-19 tests has been labelled ‘the Achilles 
heel’ of the local response to the pandemic.22 The in- hos-
pital TOT improved once the criteria for community 
testing were changed, from all people with relevant symp-
toms to only those over 55 years or with comorbidities or 
with more than mild disease.23
Antibiotics were presumably given as the diagnosis was 
not confirmed in the majority of patients and the patient 
were treated as a community- acquired pneumonia with 
COVID-19 as part of the differential diagnosis. Steroids 
were only given in 28% of patients, but the evidence of 
their effectiveness were only announced in June 2020,24 
which was the last month of this study period.
Basic imaging with a chest radiograph was only 
performed in half the patients, which mirrors the large 
number of mild cases who did not require imaging. All 
district hospitals had access to radiography, although 
not always 24 hours a day and in some cases the clinician 
may have judged that management of the patient would 
Table 6 Risk factors for death from COVID-19
Variable
Unadjusted OR
(95% CI) P value
Cancer on treatment 12.63 (3.5 to 42.3) <0.001
Chronic kidney disease 10.65 (6.21 to 18.28) <0.001
Cancer previous 8.16 (0.51 to 131.14) 0.138
Cardiac failure 5.63 (3.21 to 9.87) <0.001
Post- TB SLD 4.14 (1.23 to 13.9) 0.022
Hypertension 3.95 (2.73 to 5.70) <0.001
Type 2 diabetes 3.1 (2.2 to 4.3) <0.001
TB on treatment 2.94 (1.14 to 7.57) 0.026
Ischaemic heart disease 2.06 (0.76 to 5.58) 0.154
Hypercholesterolaemia 1.88 (1.04 to 3.37) 0.035
TB previous 1.88 (0.89 to 3.95) 0.097
Overweight/Obese 1.69 (1.15 to 2.49) 0.007
HIV 1.67 (1.09 to 2.56) 0.019
Male sex 1.63 (1.16 to 2.30) 0.005
COPD 1.34 (0.59 to 3.03) 0.487
Asthma 1.11 (0.52 to 2.36) 0.795
Type 1 diabetes 1.08 (0.24 to 4.78) 0.916
Increasing age 1.06 (1.05 to 1.07) <0.001
Turnaround time 1.02 (0.99 to 1.06) 0.216
Tobacco smoking 1.01 (0.46 to 2.21) 0.986
Length of admission 0.97 (0.93 to 1.02) 0.219
Rural versus metro 
services
0.77 (0.51 to 1.16) 0.208




Cancer on treatment 7.45 (1.87 to 29.89) 0.004
Chronic kidney disease 5.16 (2.82 to 9.43) <0.001
HIV 3.41 (2.06 to 5.65) <0.001
Cardiac failure 2.85 (1.52 to 5.35) 0.001
Male sex 2.02 (1.37 to 2.98) <0.001
Type 2 diabetes 1.84 (1.24 to 2.73) 0.002
Overweight/Obese 1.58 (1.02 to 2.46) 0.04
Increasing age 1.06 (1.04 to 1.07) <0.001
COPD, chronic obstructive pulmonary disease; SLD, structural 
lung damage; TB, tuberculosis.
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not be changed. In addition, radiography might have 
been avoided in order to reduce exposure of people to 
COVID-19 as patients would have to traverse the hospital 
to access the radiography unit if a mobile radiograph was 
not available. Not all critically ill received a radiograph 
and this might be because they died before a radiograph 
could be taken or were transferred. Patients were referred 
on the basis of the clinical picture and a radiograph was 
not essential.
Clinical outcomes at district hospitals
Overall in- hospital mortality for COVID-19 was 11% and 
rose to 20% in those admitted. Mortality was significantly 
higher in MHS facilities compared with RHS and this 
most likely reflects the higher severity of patients, rather 
than differences in management of patients. Mortality 
rates reported from a field hospital in Ethiopia were 
much lower (5.3%) despite a similar profile of COVID-19 
severity in those seen.25 This may be explained by much 
lower levels of comorbidity. For example, no HIV or TB 
was reported and diabetes was found in 14% as opposed 
to 25% of patients.
A local population cohort study also found an associa-
tion between people living with HIV and mortality from 
COVID-19 and no clear association with viraemia or 
immunosuppression.26 However, in district hospitals we 
found no association with previous or current TB infec-
tion and mortality from COVID-19, while the population 
cohort study found a twofold increase. The population 
study may have overestimated risks as routine data did not 
include all comorbidities and these patients were more 
likely to be followed up and diagnosed with COVID-19. 
Other respiratory conditions such as asthma, COPD 
and post- TB structural lung disease were also not asso-
ciated with increased mortality. This could suggest that 
immunological factors were maybe more important than 
pulmonary factors in determining risk of death. Other 
conditions with impaired or altered immunity were also 
associated with mortality, such as type 2 diabetes and 
people receiving treatment for cancer.
The combination of increasing age, overweight/obesity, 
type 2 diabetes, chronic kidney disease and cardiac 
failure as independent risk factors is important as one in 
two South Africans over the age of 45 years have predia-
betes or diabetes.27 Increasing age, obesity and chronic 
kidney disease were also identified as key risk factors in 
the Democratic Republic of Congo28 and diabetes in Ethi-
opia. The importance of non- communicable diseases, 
such as diabetes, was brought into the public spotlight by 
COVID-19 as previously the focus of attention was on HIV 
and TB. The level of control of diabetes was also directly 
related to risk of mortality, which emphasised the need 
to improve self- management and treatment, particularly 
as 57% had a history of poor control on admission. The 
absence of electronic medical records and an integrated 
health information system explains why hospitals could 
not obtain information on prior control of chronic 
diseases, particularly in the RHS. The continuity of care 
for type 2 diabetes was also disrupted by the de- escalation 
of services and most forms of patient education and coun-
selling were stopped. There is a need to innovate new 
ways of managing and empowering people with diabetes 
while reducing their risk of exposure to COVID-19 at 
health facilities and support groups.
All results were dependent on the completeness and 
accuracy of medical records. For example, clinicians may 
not have recorded all the symptoms experienced by the 
patients. Family physicians did not report a problem with 
missing medical records. It would have been helpful to 
record the antiretroviral treatment regimen in patients 
with HIV and to investigate any association between 
mortality and exposure to different combinations of 
medications. No data were collected on laboratory results 
such as full blood count, urea or creatinine or on the 
time between onset of symptoms and treatment, and this 
might have been useful to investigate the relationship 
with clinical outcomes. It was not possible to determine 
the outcomes of patients that were discharged from the 
EC with mild disease and it is possible that some were 
re- admitted to other hospitals. None of the family physi-
cians collecting data reported that patients in the study 
were re- admissions.
These hospitals all had family physicians heading their 
clinical teams and it is possible that they had a higher 
quality of care than the hospitals that are still without 
them. The Western Cape also has better infrastructure 
and a stronger health system than many other provinces 
and the quality of care is likely to be lower in other parts 
of South Africa.
CONCLUSIONS
District hospitals provided an essential primary care 
service for many patients with mild symptoms of COVID-19 
during the epidemic. This also represented a deficiency 
in access to and utilisation of primary care. District hospi-
tals successfully treated a large number of people with 
moderate- to- severe COVID-19 who did not need ventila-
tion and took pressure off higher- level facilities. Limited 
laboratory capacity meant that most patients were treated 
as people under investigation without a definitive diag-
nosis. The clinical picture was similar to that reported 
elsewhere. Mortality at this level of care was associated 
with increasing age, male sex, HIV, type 2 diabetes, over-
weight/obesity, cardiac failure, chronic kidney disease 
and treatment for cancer, but not with hypertension, TB, 
asthma, COPD or post- TB lung damage. Patients in the 
MHS were more numerous, had more comorbidity and 
more severe COVID-19 disease than in the RHS.
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